STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas
Szeman Ruby Chan(Washington University in St. Louis), Robert D. Schreiber(Parker Institute for Cancer Immunotherapy)
Cited by 198
Related Papers
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
|The Journal of Experimental Medicine|2011|1k
Tumor neoantigens: building a framework for personalized cancer immunotherapy
|Journal of Clinical Investigation|2015|631
Vav proteins control MyD88-dependent oxidative burst
|Blood|2006|83
Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma
|Blood Advances|2024|12
Sex as a Biologic Variable in Preclinical Imaging Research: Initial Observations with <sup>18</sup>F-FLT
|Journal of Nuclear Medicine|2017|7